Answers are grounded in this paper and cite their sources.
The article attempts to set harm minimization within drug settings into a larger framework of harm minimization practices. It seeks to provide a plausible account of harm reduction and then explores four ethical challenges for harm reduction strategies.
No takes yet. Share an insight, caveat, or question.
John Kleinig (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: